Vis enkel innførsel

dc.contributor.authorAmundsen, Tore
dc.contributor.authorSørhaug, Sveinung
dc.contributor.authorLeira, Håkon Olav
dc.contributor.authorTyvold, Stig Sverre
dc.contributor.authorLangø, Thomas
dc.contributor.authorHammer, Tommy Arild
dc.contributor.authorManstad-Hulaas, Frode
dc.contributor.authorMattsson, Erney
dc.date.accessioned2020-06-09T06:33:25Z
dc.date.available2020-06-09T06:33:25Z
dc.date.created2016-11-12T11:58:29Z
dc.date.issued2016
dc.identifier.issn2001-8525
dc.identifier.urihttps://hdl.handle.net/11250/2657257
dc.description.abstractBackground Malignant airway obstruction is a feared complication and will most probably occur more frequently in the future because of increasing cancer incidence and increased life expectancy in cancer patients. Minimal invasive treatment using airway stents represents a meaningful and life-saving palliation. We present a new removable airway stent for improved individualised treatment. Methods To our knowledge, the new airway stent is the world's first knitted and uncovered self-expanding metal stent, which can unravel and be completely removed. In an in vivo model using two anaesthetised and spontaneously breathing pigs, we deployed and subsequently removed the stents by unravelling the device. The procedures were executed by flexible bronchoscopy in an acute and a chronic setting – a ‘proof-of-principle’ study. Results The new stent was easily and accurately deployed in the central airways, and it remained fixed in its original position. It was easy to unravel and completely remove from the airways without clinically significant complications. During the presence of the stent in the chronic study, granulation tissue was induced. This tissue disappeared spontaneously with the removal. Conclusions The new removable stent functioned according to its purpose and unravelled easily, and it was completely removed without significant technical or medical complications. Induced granulation tissue disappeared spontaneously. Further studies on animals and humans are needed to define its optimal indications and future use.en_US
dc.language.isoengen_US
dc.publisherTaylor & Francis Openen_US
dc.relation.urihttp://www.tandfonline.com/doi/pdf/10.3402/ecrj.v3.30010?needAccess=true
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleA new removable airway stenten_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.volume3en_US
dc.source.journalEuropean Clinical Respiratory Journalen_US
dc.source.issue1en_US
dc.identifier.doi10.3402/ecrj.v3.30010
dc.identifier.cristin1399749
dc.description.localcode#2016 Tore Amundsen et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution4.0 International License (http://creativecommons.org/licenses/by/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix,transform, and build upon the material for any purpose, even commercially, provided the original work is properly cited and states its licenseen_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal